Precisely - if results impending from current studies and trials (which are funded with current cash) show solid promise over the next 6-12 months, then the SP will appreciate in recognition of that success and further de-risking as we move towards further phases/registration.
No doubt additional funding will be needed in future to fund other trials, but they should be from a higher SP basis by that time assuming current studies demonstrate positive results. Also likely that those funds will be sourced from 'sophisticated investors'or via partnerships, as retail offers are always time consuming, more costly and frankly messier. No issue with additional funding if it is well-spent. No indications to date that the company is frivilous with it's wallet, and I see no reason for those tight purse-strings not being maintained into the future.
PTX Price at posting:
29.5¢ Sentiment: Hold Disclosure: Held
